7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Structure Therapeutics Inc.
(NASDAQ:GPCR) 

GPCR stock logo

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 r...

Founded: 2016
IPO Price: $15 (Feb 03, 2023)
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Structure Therapeutics Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0261.4522.81784.211,045.611,307.021,568.421,829.82
Structure Therapeutics Op Cashflow Per Share ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.92-1.65-1.37-1.1-0.82-0.55-0.270
Structure Therapeutics Free Cashflow Per Share ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.93-1.65-1.38-1.1-0.83-0.55-0.280
Structure Therapeutics Cash Per Share ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.442.884.325.767.28.6410.08
Structure Therapeutics (GAAP) P/E ratio ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -39.86-34.17-28.47-22.78-17.08-11.39-5.690
Structure Therapeutics P/B ratio ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.783.565.347.128.9110.6912.47
No extra charts and metrics for this ticker.